Last reviewed · How we verify
NCT06370559
Relationship Between Repetitive Negative Thinking and CBT Outcomes
trial in Anxiety Disorders in 320 participants. Completed in 1 February 2024.
1 February 2024
Quick facts
| Lead sponsor | South London and Maudsley NHS Foundation Trust |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 320 |
| Start date | 1 January 2022 |
| Primary completion | 1 February 2024 |
| Estimated completion | 1 February 2024 |
| Sites | 1 location across United Kingdom |
Conditions studied
- Anxiety Disorders — all drugs for Anxiety Disorders →
- Obsessive-Compulsive Disorder — all drugs for Obsessive-Compulsive Disorder →
- Post-traumatic Stress Disorder — all drugs for Post-traumatic Stress Disorder →
- Social Anxiety Disorder — all drugs for Social Anxiety Disorder →
Sponsor
South London and Maudsley NHS Foundation Trust
Who can join
18 and older, any sex, with Anxiety Disorders or Obsessive-Compulsive Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to learn about the role of repetitive negative thinking (measured by the RTQ) in adult populations from an anxiety disorders and trauma clinic. The main questions it aims to answer are: * Whether the repetitive negative thinking can be used to predict i. initial symptom severity, and ii. therapy outcome (measured by change in scores on disorder specific measures). * Whether change in RTQ mediates change in outcome Participants are sent weekly questionnaires that measure their progress. Within these questionnaires are the RTQ and other disorder-specific measures that we will be analysing. Researchers may also compare clients with different disorders to see the accuracy the RTQ can predict treatment outcomes for each disorder.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06370559
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anxiety Disorders
Currently open trials in the same condition.
- NCT07340281 — Biomarkers for Exercise · NA · recruiting
- NCT07432945 — In Vivo Exposure vs. Videochat-Based Vicarious Exposure · NA · recruiting
- NCT07316374 — AI Chatbots for Anxiety Mental Health Literacy · NA · active not recruiting
- NCT07123467 — Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder · Phase 3 · recruiting
- NCT07174947 — SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depre · Phase 2 · recruiting
Other South London and Maudsley NHS Foundation Trust trials
Trials by the same sponsor.
- NCT06989151 — Cognitive Remediation for Autistic Adolescents · EARLY_PHASE1 · completed
- NCT06014268 — Electronic Clinical Decision Support System (eCDSS) for Prevention of Atrial Fibrillation-related Stroke · unknown
- NCT05220436 — DISCOVER Workshop Programme for Care Experienced Young People · NA · completed
- NCT03946540 — Longitudinal Follow Up of Eating Disorder Treatment · unknown
- NCT03196128 — Early Intervention Psychosis Communication and Engagement Trial · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06370559 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by South London and Maudsley NHS Foundation Trust
- Last refreshed: 17 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06370559.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing